AI in Pharmaceutical Cleanrooms
Overcoming the Thermal and Airflow Challenges of Heat-Emitting AI-Workstations

A guest post by Arista 2 min Reading Time

Related Vendors

To meet FDA recommendations for local data processing, high-performance computing is moving directly to the equipment. Decentralized single-GPU systems enable real-time analysis and control directly at the production line. Specialized thermal management ensures stable operation without compromising cleanroom integrity.

The FDA notes that execution-control software should be located as close as possible to its associated equipment to avoid adverse effects on performance or security.(Source:  Arista Corporation)
The FDA notes that execution-control software should be located as close as possible to its associated equipment to avoid adverse effects on performance or security.
(Source: Arista Corporation)

Artificial intelligence (AI) is growing at a rapid pace and is becoming increasingly significant in pharmaceutical manufacturing. Within the past few years, there have been tremendous advances in using AI for process design, scale-up, advanced process control (APC), smart monitoring, maintenance, visual inspection, and trend monitoring for deviations and Corrective and Preventive Action (CAPA).

FDA Requirements for Local Execution

As AI becomes more integrated into pharmaceutical manufacturing, the physical location of the hardware becomes a critical factor. The FDA notes that execution-control software should be located as close as possible to its associated equipment to avoid adverse effects on performance or security. For this use case, local single-GPU systems are ideal. These compact platforms provide a cost-effective basis for AI deployment, handling the intensive mathematical processing required for data collection, machine learning, vision inspection, modeling, and inferencing directly at the workload.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent